Sustained Lesion and Shedding Rate Reductions in Genital Herpes Patients 24 Months after Immunization with GEN-003, a Genital Herpes Immunotherapy

BACKGROUND: Herpes simplex viruses (HSVs) are the main cause of genital ulcers worldwide. GEN-003 is an investigational genital herpes immunotherapy composed of HSV-2 antigens gD2DTMR and ICP4.2, and the saponin-based adjuvant Matrix-M2(TM) (MM2). In a Phase 2 dose-ranging study (GEN-003-002), 3 dos...

Descripción completa

Detalles Bibliográficos
Autores principales: Heineman, Thomas, Mcneil, Lisa K, Oliphant, Thomas, Natenshon, Andrew, Van Wagoner, Nicholas, Flechtner, Jessica B, Hetherington, Seth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632159/
http://dx.doi.org/10.1093/ofid/ofx163.720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632159/
http://dx.doi.org/10.1093/ofid/ofx163.720

Ejemplares similares